Journals / Turkish Journal of Medical Sciences / 2001 / Cilt: 31 - Sayı: 4

Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation

Pages
329–335
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation
📊
Key Findings & Data:Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation
💡
Conclusion & Impact:Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation

🔖

Cite This Article

AKBAY, A., DEMİRTAŞ, S., TUNCER, T. E., CANBOLAT, O., GENÇ, Y., AYDEMİR, Ç. (2022). Antioxidant status, lipid peroxidation products and cystatin C as potential clinical markers of Alzheimer's disease in systemic circulation. Turkish Journal of Medical Sciences, Cilt: 31 - Sayı: 4, 329–335. https://ajindex.com/articles/612265

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Simonian NA, Coyle ST. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83- 106, 1996 2. Multhaup G. Ruppert T, Schlicksupp A, Hesse L, Beher D, Masters CL, Beyreuther K. Reactive oxygen species and AlzheimerÕs Disease. Biochemical Pharmacology 54
  2. 39, 1997 3. Yankner B, Dawes L, Fisher S, Villa- Kamaroff L, Oster-Granite M, et al. Neurotoxicity of a fragment of the amyloid precursor associated with AlzheimerÕs disease. Science 245
  3. 20, 1989 4. Behl C, Davis J, Cole GM, Schubert D. Vitamin E protects nerve cells from amyloid b protein toxicity. Biochem Biophy Res Commun 186
  4. 50, 1992 5. Behl C, Davis J, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid b protein toxicity. Cell 77
  5. 27, 1994 6. Selkoe D. The molecular pathology of Alzheimer's disease. Neuron 6
  6. 498, 1991 7. Dyrks T, Dyrks E, Hartman T, Masters C, Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal catalyzed oxidation. J Biol Chem 267
  7. 18210-17, 1992 8. Palmer A, Burris M. Selective increase in lipid peroxidation in the inferior temporal cortex in AlzheimerÕs disease. Brain Res 645
  8. 42, 1994 9. Markesbery WR. Oxidative stress hypothesis in AlzheimerÕs disease. Free Radic Biol Med 23
  9. 47, 1997 10. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. No evidence for systemic oxidant stress in ParkinsonÕs or AlzheimerÕs disease. Mov Disord 10
  10. 73, 1995 11. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR. Altered plasma antioxidant status in subjects with AlzheimerÕs disease and vascular dementia. Int J Geriatr Psychiatry 13
  11. 5, 1998 12. De Leo ME, Borrello S, Passantino M, Palazzotti B, Mordente A, Daniele A, Filippini V, Galeotti T, Masullo C. Oxidative stress and overexpression of mangenese superoxide dismutase in patients with AD. Nurosci Lett 250
  12. 6, 1998 13. Davidson P, Ekman R, Blennow K. A new procedure for detecting brain specific proteins in cerebrospinal fluid. Journal of Neural Transmission 104
  13. 20, 1997 14. Davidson P, Ekman R, Blennow K. A new procedure for detecting brain specific proteins in cerebrospinal fluid. Journal of Neural Transmission 104: 711-720, 1997 15. Malloy MF, Cummings JL, Coffey CE, Duffy J, Fink M, Lauterbach EC, Lovell M, Royall D, Salloway S. Cognitive screening instruments in neuropsychiatry: a report of the committee on research of the American Neuropsychiatric Association. J Neuropsychiatry